Outcome of patients with therapy-related acute myeloid leukemia with or without an antecedent history of myelodysplasia

Microabstract: The presence of antecedent hematologic disorders at diagnosis of therapy-related acute myeloid leukemia did not affect overall survival. The favorable risk cohort had better relapse-free survival and overall survival as compared to the outcomes of patients in the intermediate and adverse risk cohorts; the relapse-free survival and overall survival did not differ between intermediate and adverse cohorts.

Source: Clinical Lymphoma, Myeloma and Leukemia - August 9, 2016 Category: Hematology Authors: Koji Sasaki, Elias Jabbour, Jorge Cortes, Tapan Kadia, Guillermo Garcia-Manero, Gautam Borthakur, Preetesh Jain, Sherry Pierce, Naval Daver, Koichi Takahashi, Susan O ’Brien, Hagop Kantarjian, Farhad Ravandi Tags: Original Study Source Type: research